Cross-fund · 5 holders
NTLA
INTELLIA THERAPEUTICS INC
CUSIP 45826J105
5
Tracked holders
$291.8M
Aggregate value
26,651,018
Shares
6
Active funds
Funds holding NTLA
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $155.8M | — | +1,878,957 | +18.3% |
| Vanguard | Institutional | Q4 2025 | $117.0M | — | +1,965,181 | +17.8% |
| Citadel | Multi-Strategy | Q1 2026 | $14.3M | — | −1,020,309 | −47.7% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $3.8M | — | +272,911 | +1132.4% |
| Millennium | Multi-Strategy | Q1 2026 | $904,566 | — | −55,867 | −44.2% |
| BridgewaterFEAT | Macro | Q1 2026 | — | — | −223,166 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.